Read more
11:21 · 15 January 2026

TSMC just broke the bank❗️💰 Profits surge record 35% 📈

TSMC closed the fourth quarter with record results, posting a 35% surge in profits and crushing analysts’ forecasts. The semiconductor giant is showing resilience to geopolitical uncertainty and potential tariffs, benefiting from the global AI boom that continues to fuel its growth streak. The results are an important signal for Wall Street about momentum in the AI sector and could point to a return of strong gains in stocks such as Nvidia and AMD.

 

Financial Highlights

  • Earnings Beat: Net income reached NT$505.74 billion, surpassing the consensus estimate of NT$478.4 billion.

  • Revenue Milestone: Quarterly revenue crossed the NT$1 trillion mark for the first time ($33.09 billion), driven by an eight-quarter streak of year-over-year profit growth.

  • Capex Update: Capital expenditure for 2025 totaled $40.9 billion, landing squarely within the company's guidance range of $40–42 billion.

 

Strategic Drivers

  • AI Dominance: High-performance computing remains the primary engine of business; advanced chips (7nm or smaller) now account for 77% of wafer revenue.

  • US Investment Push: TSMC is solidifying its US footprint with a total projected investment of $165 billion—comprising an initial $65 billion and a newer $100 billion commitment made with President Trump. One Arizona facility is already operational, with further expansion expected as part of pending trade deals.

  • Market Outlook: While AI demand is robust, the company faces headwinds in the mobile sector, with analysts predicting an 11.6% drop in smartphone shipments in 2026 due to memory shortages.

 

TSM.US (D1)

TSMC shares are up about 2.5% in pre-market trading on Wall Street, despite the daily RSI hovering near overbought levels. The price is therefore erasing the losses of the past two sessions that were driven by pre-earnings anxiety, although buyers remain cautious about pushing the stock above its latest all-time high.

Source: xStation5

14 April 2026, 18:13

US OPEN: Wall Street Rallies on Soft PPI Data

14 April 2026, 17:52

Novo Nordisk announces a strategic partnership with OpenAI🧬🤖

14 April 2026, 16:52

Wells Fargo Q1 2026: Profit Growth Masks Deterioration in Earnings Quality

14 April 2026, 15:47

JP Morgan earnings: Good, but it could have been better

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.